Compare Neurocrine Biosciences Inc (NBIX) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs D Wave Quantum Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while D Wave Quantum Inc trades at $17.93 (market cap $6.19B). The key difference: Neurocrine Biosciences Inc is far larger — about 2.8× D Wave Quantum Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | QBTS | |
|---|---|---|
Market Cap | $17.40B | $6.19B |
Sector | Health | Technology |
52-Week High | $180.55 | $44.78 |
52-Week Low | $123.10 | $12.98 |
Enterprise Value | $16.49B | $5.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
